Long Noncoding RNA TUG1 Promotes the Function in ox-LDL-Treated HA-VSMCs via miR-141-3p/ROR2 Axis

Figure 1

The expression of TUG1 and miR-141-3p in tissues of patients with AS and in ox-LDL-treated HA-VSMCs. (a) qRT-PCR was used to detect the expression of lncRNA TUG1 in tissues from 30 patients with atherosclerosis, compared with those from 30 healthy volunteers. (b) The expression of miR-141-3p in tissues was detected by qRT-PCR assay. (c) A correlation analysis between the expression TUG1 and miR-141-3p was shown. (d, e) HA-VSMCs were incubated with ox-LDL at various concentrations (0 μg/mL, 25 μg/mL, 50 μg/mL, and 75 μg/mL) for 24 h, followed by qRT-PCR assay of TUG1 (d) and miR-141-3p (e) expression. .

(a)

(b)

(c)

(d)

(e)